EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Radioiodine ablation in a haemodialysis-dependent patient with papillary thyroid carcinoma

Aisha Salem Alzahmi, Thoraia Awad Abdelrahman, Asif Moin, Hiba Drwesh, Mohammed Hassan Al Ali, Hessa Ebrahim Boharoon

Endocrinology, Diabetes & Metabolism Case Reports · 01.04.2026 · 2026 (2)

DOI: 10.1530/edm-25-0153 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, online erschienen am 01.04.2026. Verfasst von Aisha Salem Alzahmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of differentiated thyroid cancer with radioactive iodine (RAI) in patients with end-stage renal disease (ESRD) on haemodialysis is particularly challenging because of impaired iodine clearance, prolonged radiation exposure and safety concerns for healthcare personnel. We present the case of a 54-year-old male on thrice-weekly maintenance haemodialysis who was incidentally diagnosed with papillary thyroid carcinoma during pre-transplant assessment. He underwent total thyroidectomy followed by adjuvant RAI ablation, planned on the basis of the available literature. A reduced dose of 50 mCi (1.85 GBq) was administered after stimulation with recombinant human TSH, and dialysis was scheduled at 48 h post-therapy to optimize uptake, with additional sessions on Days +3 and +6. Ablation was successful, with iodine-avid tissue seen on post-therapy imaging and no significant complications observed. This case demonstrates that with individualized dosing, tailored dialysis scheduling and multidisciplinary coordination, RAI ablation can be performed safely and effectively in patients with ESRD on haemodialysis, despite the absence of standardized guidelines. Learning points

Schlagwörter

Stichwörter der Autor:innen

case reportend-stage renal diseasehemodialysispapillary thyroid carcinomaradioiodine ablation

Autor:innen und Institutionen

  • Department of Internal Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
  • Department of Nuclear Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
  • Department of Radiology, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
  • Department of Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
  • Department of Otolaryngology-Head and Neck Surgery, Sheikh Khalifa Medical City, Abu Dhabi, UAE.

Zitieren

APA

Alzahmi, A. S., Abdelrahman, T. A., Moin, A., Drwesh, H., Al Ali, M. H., & Boharoon, H. E. (2026). Radioiodine ablation in a haemodialysis-dependent patient with papillary thyroid carcinoma. Endocrinology, Diabetes & Metabolism Case Reports, 2026(2). https://doi.org/10.1530/edm-25-0153

Vancouver

Alzahmi AS, Abdelrahman TA, Moin A, Drwesh H, Al Ali MH, Boharoon HE. Radioiodine ablation in a haemodialysis-dependent patient with papillary thyroid carcinoma. Endocrinology, Diabetes & Metabolism Case Reports. 2026;2026(2). doi:10.1530/edm-25-0153

BibTeX
@article{Alzahmi2026,
  author = {Alzahmi, Aisha Salem and Abdelrahman, Thoraia Awad and Moin, Asif and Drwesh, Hiba and Al Ali, Mohammed Hassan and Boharoon, Hessa Ebrahim},
  title = {Radioiodine ablation in a haemodialysis-dependent patient with papillary thyroid carcinoma},
  journal = {Endocrinology, Diabetes & Metabolism Case Reports},
  year = {2026},
  volume = {2026},
  number = {2},
  doi = {10.1530/edm-25-0153}
}
Kostenlos starten →